Cargando…
Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk
The renin-angiotensin system (RAS), besides being a major regulator of blood pressure, is also involved in tumor angiogenesis. Emerging evidence suggests a correlation between the use of pharmacologic RAS inhibitors and a delay in urothelial bladder cancer (BC) progression. However, it is unknown wh...
Autores principales: | Samara, Maria, Papathanassiou, Maria, Farmakioti, Ioanna, Anagnostou, Maria, Satra, Maria, Mitrakas, Lampros, Anastasiou, Dimitrios, Chasiotis, Georgios, Christopoulos, Agamemnon, Anagnostou, Athanasios, Christodoulou, Anastasios, Daponte, Alexandros, Ioannou, Maria, Koukoulis, George, Tzortzis, Vassilios, Vlachostergios, Panagiotis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628720/ https://www.ncbi.nlm.nih.gov/pubmed/34898568 http://dx.doi.org/10.3390/curroncol28060396 |
Ejemplares similares
-
DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population
por: Samara, Maria, et al.
Publicado: (2021) -
Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma
por: Mitsogiannis, Iraklis C., et al.
Publicado: (2022) -
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2022) -
Poorly differentiated muscle-invasive giant cell tumor of the bladder leads to unfavorable clinical outcome
por: Karasavvidou, Foteini, et al.
Publicado: (2022) -
Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis
por: Papathanassiou, Maria, et al.
Publicado: (2022)